BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ENTrigue Surgical, Inc. 

12672 Silicon Drive
Suite 150
San Antonio  Texas  78249  U.S.A.
Phone: 210-298-6398 Fax: 210-298-6399


SEARCH JOBS


Industry
Medical Device






 Company News
ArthroCare Corporation (ARTC) Nabs ENTrigue Surgical, Inc. for $45 Million 7/2/2013 10:07:53 AM    More...
ENTrigue Surgical, Inc. Introduces Ventera®-R Sinus Dilation System for the U.S. 9/20/2012 10:38:00 AM    More...
ENTrigue Surgical, Inc. Announces Sinus Surgery Collaboration With fiagon GmbH 9/6/2012 11:57:36 AM    More...
ENTrigue Surgical, Inc. Announces Initial Clinical Experience with Ventera(TM) Sinus Dilation Systems and the Commercial Launch of Synaero(TM) Hemostasis Product 9/23/2010 9:13:13 AM    More...
RTI Biologics, ENTrigue Surgical, Inc. Announce Development and Supply Agreement For Tutoplast(R)-Processed Tissues 12/15/2008 11:28:51 AM    More...
ENTrigue Surgical, Inc. Announces Product Commercialization 9/18/2008 10:51:11 AM    More...

//-->